Whalesbook
PI Industries ke March quarter ke financial results ne market ki expectations ko phir se tod diya hai, jo agrochemical sector mein chal rahi problems ko dikha raha hai.
Consolidated net profit pichle saal ke muqable 39.4% gir gaya, jo Rs 331 crore tha woh ab Rs 200 crore ho gaya. Revenue bhi 12.4% kam hokar Rs 1,565 crore raha, jo pehle Rs 1,787 crore tha. EBITDA bhi 26.1% ghir kar Rs 337 crore pe aa gaya.
Margin Compression aur Guidance Miss
Company ka EBITDA margin bhi kam hokar 21.5% ho gaya, jo pichle saal is time 25.5% tha. Ye performance company ke khud ke guidance 25% to 27% se kaafi neeche tha, jo operational challenges ko bata raha hai. Itna bura result aane ke baad bhi, board ne final dividend Rs 10 per share propose kiya hai.
Baar Baar Expectations Miss
Ye results is baat ka saboot hain ki PI Industries ne pichle 9 quarters mein se 7 baar analysts ki projections ko miss kiya hai. Company ka EBITDA is quarter mein Street estimates se lagbhag 15% kam tha. Management ne customer delivery schedules mein delays ko iska main reason bataya hai, jisne revenue recognition ko impact kiya.
Performance Ko Kisne Affect Kiya?
Global agrochemical industry mein slowdown ki wajah se export demand par dabav bana raha. India mein, zyada channel inventory, aggressive pricing, aur kam crop acreage ne operations ko constrain kiya. Pyroxasulfone jaise kuch specific products mein expectations se kam volumes aur realization hone se bhi earnings par asar pada.
FY27 Ke Liye Kya Hai Outlook?
Is setbacks ke bawajood, PI Industries management fiscal year 2027 ke liye optimistic hai. Company ko lagbhag 5 naye molecules launch karne ki ummeed hai, jismein strong order book aur pipeline visibility ka support rahega. Agrochemical business mein dheere-dheere recovery ki ummeed hai jab global demand badhegi aur inventory levels normal honge. Biologicals segment mein bhi regulatory approvals se rebound ki ummeed hai, jabki pharmaceutical division naye partnerships se positive momentum dikha raha hai. Management cautiously optimistic hai aur FY27 ke second half mein accelerated growth ka forecast kar raha hai jab naye products traction pakdenge aur market conditions sudhrenge.